To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
De Vivo disease
De Vivo disease is an autosomal dominant disease associated with a deficiency of GLUT1. Additional recommended knowledge
PresentationChildren with this disease presents with refractory seizure disorder , ataxia, and developmental delay with deceleration of head growth and microcephaly.1 The seizure is usually an infantile- onset often begin at 1-4 months of age.2 usually starts as complex seizure and later in childhood becomes more generalized.the frequency of seizure is variable and a history of decreasing seizure frequency during times of ketosis (ex: during an illness) should prompt the diagnosis2 Seizure is usually refractory to anticonvulsants and it might be exacerbated by phenobarbitaone.2 Developmental delay is global and includes receptive and expressive language dysfunction.2 Ataxia, fine motor control problems is also global.2 DiagnosisCSF glucose value, (<2.2 mmol/L), or lowered CSF/Plasma glucose ratio( <0.4), erythrocyte 3-O-methyl-d-glucose uptake assay. TreatmentKetogenic diet helps control the seizure by providing ketones as an alternative fuel to the brain instead of glucose.[1] References
2-Journal of paediatrics and child health 42(2006) 263-267 |
|||
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "De_Vivo_disease". A list of authors is available in Wikipedia. |